Abstract: A troche comprising at least 5 mg hyaluronan, wherein the troche is adherent, and wherein hyaluronan is released from the troche, is used to treat mucositis, including stomatitis, vestibulitis, aphthous ulcerations, lichen planus and Behcet's syndrome. A method for treating or preventing mucositis in a patient is provided, comprising applying to a mucosal surface or a tooth or orthodontic brace of a patient in need thereof an adhering troche comprising at least 5 mg hyaluronan.
Abstract: A method of treating a condition of a mammal, including a human individual and an animal, by intravenously administering a therapeutically effective amount of a poly -oxygenated metal hydroxide. In some embodiments, the poly-oxygenated metal hydroxide is an aluminum poly-oxygenated hydroxide, such as Ox66™. The poly-oxygenated metal hydroxide may have particles having a diameter of less than or equal to 1 um, and specifically having a diameter of less than or equal to 100 nm. The poly-oxygenated metal hydroxide may be 75-90% colloid or crystalline solution with 10-25% addition of poly-oxygenated metal hydroxide particles.
Type:
Grant
Filed:
November 8, 2016
Date of Patent:
June 20, 2017
Assignee:
Baylor University
Inventors:
Erica D. Bruce, Christie Sayes, John W. Woodmansee, Jr.
Abstract: A personal care photoprotective composition is provided having a UV-A and UV-B sunscreen in conjunction with a tricyclodecane amide. The tricyclodecane amide functions to boost UV-A, UV-B and SPF performance when the personal care composition is applied to skin or hair of the human body.
Type:
Grant
Filed:
March 10, 2014
Date of Patent:
June 20, 2017
Assignee:
Conopco, Inc.
Inventors:
Van Au, Bijan Harichian, Ian Stuart Cloudsdale, John Steven Bajor, John Kenneth Dickson, Jr.
Abstract: Products and methods are disclosed for reducing the production of unwanted odors from the pudendum. The products include an acidifying composition comprising one or more carboxylic acids such as mandelic acid or salts thereof and xanthine compounds such as caffeine or salts thereof. The methods include application of the products to the pudendum in any of a variety of ways to effectively reduce unwanted odors.
Abstract: The present invention has discovered that 7,8-dihydroxy-2-phenyl-4H-chromen-4-one and a salt thereof have unexpected and advantageous cooling enhancement and modification properties. Thus, a composition comprising a cooling compound and an effective amount of 7,8-dihydroxy-2-phenyl-4H-chromen-4-one can be used to enhance or modify the cooling sensation in the mouth, in the nasal cavity and/or on the skin, and can also augment, enhance or impart a cooling sensation to products such as foodstuff, chewing gums, dental or oral hygiene products, topical products, nasal care products and toilet articles.
Type:
Grant
Filed:
September 25, 2015
Date of Patent:
June 6, 2017
Assignee:
INTERNATIONAL FLAVORS & FRAGRANCES INC.
Inventors:
Hou Wu, Thumpalasseril V. John, Xiaoqing Tang, Jung-A Kim
Abstract: A method of treating a condition of a mammal, including a human individual and an animal, by intravenously administering a therapeutically effective amount of a poly-oxygenated metal hydroxide. In some embodiments, the poly-oxygenated metal hydroxide is an aluminum poly-oxygenated hydroxide, such as Ox66™. The poly-oxygenated metal hydroxide may have particles having a diameter of less than or equal to 1 um, and specifically having a diameter of less than or equal to 100 nm. The poly-oxygenated metal hydroxide may be 75-90% colloid or crystalline solution with 10-25% addition of poly-oxygenated metal hydroxide particles.
Type:
Grant
Filed:
June 15, 2016
Date of Patent:
May 16, 2017
Assignee:
Baylor University
Inventors:
Erica D. Bruce, Christie Sayes, John W. Woodmansee, Jr.
Abstract: The disclosure relates to coatings that contain silver, either in the form of metallic silver, silver oxides, salts of silver, or combinations of these. The silver is present in a microparticulate or nanoparticulate form, which exerts antimicrobial activity when bacteria (e.g., in a body fluid) contact the coated surface. The coatings are applied through accumulation of silver-containing particles on the surface, such as by sputtering or electron beam vapor deposition. As a result, their thickness, particle size, and density can be controlled. Furthermore, the surface can also be coated with other substances, such as diamond-like carbon or alumina, either as a discrete layer or intermixed with the silver-containing particles.
Type:
Grant
Filed:
March 4, 2013
Date of Patent:
May 16, 2017
Assignee:
Rowan University
Inventors:
Robert Ostrum, Jeffrey Hettinger, Robert Krchnavek, Gregory A Caputo
Abstract: The present invention relates to a stable, sterile, ready to administer parenteral dosage form of amiodarone or its pharmaceutically acceptable salt. Particularly, the present invention provides a stable, sterile, ready to administer parenteral dosage form of amiodarone comprising an aqueous solution comprising amiodarone or its pharmaceutically acceptable salt, an acid, and a polyol, wherein the pH of the solution is in the range of about 2.0 to 4.0, wherein the solution is filled in a plastic container and wherein the solution is free of a solubilizer.
Abstract: The present invention relates to a method of consuming a universal potent healing tonic. When consumed according to the method, the arthritic user will experience a large reduction in symptoms, and possible elimination of symptoms altogether, and may also alleviate general pain in the user.
Abstract: Compositions which include a corticosteroid in combination with an additional compound active in treatment of an inflammatory disorder are provided.
Abstract: The present invention provides compositions comprising API and at least one amino acid, in particular a liquid API formulation comprising amino acids, and methods and kits related thereto. These amino acids when incorporated into the API composition afford stability to the API formulation.
Type:
Grant
Filed:
October 29, 2015
Date of Patent:
April 11, 2017
Assignee:
Grifols Therapeutics, Inc.
Inventors:
Jianxin Guo, Anthony Klos, Bret Coldren, Deborah Barnette, Mark Manning
Abstract: A stable effervescent tablet, granule or powder composition free from excipients that may react with an effervescing organic acid component, comprising, an effective amount of a bisphosphonate bone resorption inhibitor, an effervescing organic acid component, an effervescing base component; wherein said composition is free of polyol binders and tableting lubricants; has a loss on drying of 0.25% (m/m) or less; has a complete disintegration time of no more than 180 seconds when placed in 3 to 8 fluid ounces of water at between 5-20° C.; and said bisphosphonate is incorporated as a micronized particle or by spray drying and is completely solubdised in water within 2 minutes without stirring.
Abstract: Disclosed is a cosmetic composition comprising a first film-forming polymer having a contact angle of at least 85°, a second film-forming polymer having a contact angle of at least 85°, a lipid having a melting point of at least 5° C., optical particle, and at least 20% of water by weight of the composition.
Abstract: A multiparticulate composition includes a plurality of individual enteric coated cores containing one or more terpene-based active ingredients and having a continuous proteinaceous subcoating layer covering the individual cores and separating the individual cores from their respective enteric coatings. The continuous proteinaceous subcoating layer prevents volatile terpene-based active ingredients from leaving the core, even when the core is heated during processing or stored for long periods above room temperature. The multiparticulate composition may be used to treat gastrointestinal disorders.
Abstract: Disclosed herein are a composition and unit dosage form for the treatment of hepatitis C virus (HCV) infection comprising GS-7977 and at least one pharmaceutically acceptable excipient, as well as methods for making said composition and unit dosage form. Also disclosed herein is a method of treating a subject, preferably a human, infected with hepatitis C virus, said method comprising administering to the subject for a time period an effective amount of GS-7977 and an effective amount of ribavirin. In one aspect, the method comprises administering to the subject an interferon-free treatment regimen comprising an effective amount of GS-7977 and an effective amount of ribavirin. In a particular aspect, the method is sufficient to produce an undetectable amount of HCV RNA in the subject for at least 12 weeks after the end of the time period.
Type:
Grant
Filed:
November 11, 2014
Date of Patent:
January 24, 2017
Assignee:
Gilead Pharmasset LLC
Inventors:
Darryl G. Cleary, Charles J. Reynolds, Miriam Michelle Berrey, Robert G. Hindes, William T. Symonds, Adrian S. Ray, Hongmei Mo, Christy M. Hebner, Reza Oliyai, Vahid Zia, Dimitrios Stefanidis, Rowchanak Pakdaman, Melissa Jean Casteel
Abstract: The disclosure relates to sunscreen compositions having a synergistic combination of ultraviolet light (UV) filtering agents that provide a high sun protection factor (SPF). Compositions according to the disclosure have high SPF values without requiring high total amounts of UV filtering agents. Furthermore, the disclosure relates to methods of using the described compositions for protecting keratinous substances such as skin and hair from UV radiation.
Type:
Grant
Filed:
June 25, 2015
Date of Patent:
January 10, 2017
Assignee:
L'OREAL
Inventors:
Susan Halpern Chirch, Anthony Diaz-Santana, Anil Shah
Abstract: A method of making an antiperspirant active composition and the use of a heating step at elevated temperature to convert Al13 polyhydroxyoxoaluminum cations in the species detectable by 27Al NMR within an aqueous aluminum salt solution into Al30 polyhydroxyoxoaluminum cations in the species detectable by 27Al NMR without increasing a SEC Peak 3 area in the SEC chromatogram of the aluminum salt.
Abstract: The disclosure relates to sunscreen compositions having a synergistic combination of ultraviolet light (UV) filtering agents that provide a high sun protection factor (SPF). Compositions according to the disclosure have high SPF values without requiring high total amounts of UV filtering agents. Furthermore, the disclosure relates to methods of using the described compositions for protecting keratinous substances such as skin and hair from UV radiation.
Type:
Grant
Filed:
June 25, 2015
Date of Patent:
January 10, 2017
Assignee:
L'OREAL
Inventors:
Susan Halpern Chirch, Anthony Diaz-Santana, Anil Shah
Abstract: Flowable compositions and methods are provided for delivering a therapeutic agent at or near a target tissue site beneath the skin of a patient, the flowable composition comprising (i) a solvent, (ii) a polymer and (iii) an effective amount of the therapeutic agent, the flowable composition being capable of setting to form a substantially non-flowable composition at a physiological temperature or as the solvent contacts bodily fluid at or near the target tissue site, wherein the substantially non-flowable composition is capable of releasing the therapeutic agent over a period of at least one day and the target tissue site comprises at least one muscle, ligament, tendon, cartilage, spinal disc, spinal foraminal space near the spinal nerve root, facet or synovial joint, or spinal canal.
Abstract: Described herein are compositions, methods, and devices for relief of a cough, cold, sore throat, or allergy, or a related symptom. Also described herein are compositions, methods, and devices for the prevention, treatment and/or amelioration of a digestive illness or digestive discomfort, or a related symptom of either.
Type:
Grant
Filed:
May 19, 2016
Date of Patent:
November 22, 2016
Assignee:
THE FIX, LLC
Inventors:
Michael K. Allio, Stephen Lane, Marco Wo